论文部分内容阅读
近年来 ,慢性乙型肝炎的治疗 (主要是抗病毒治疗 )已取得较大进展。尤其是α 干扰素 (ＩＦＮ α)的合理应用及核苷类似物药物的开发与应用 ,对慢性乙型肝炎的治疗有了较大进步 ,但其疗效还不理想。如ＩＦＮ α在有选择的病例中对乙肝的长期疗效仅为 30 %～ 40 %。新近开发的抗
In recent years, the treatment of chronic hepatitis B (mainly antiviral therapy) has made great progress. In particular, the rational use of alpha interferon (IFN alpha) and the development and application of nucleoside analogue drugs have greatly improved the treatment of chronic hepatitis B, but its efficacy is still not satisfactory. Such as IFNα in selected cases of long-term efficacy of hepatitis B is only 30% to 40%. Newly developed resistance